Dr. Victor Dzau, Chancellor for Health Affairs at Duke University and president and CEO for Duke University Health System, has continued to remain extremely active in his lab. Before leaving Duke to serve as the next president of the Institute of Medicine, he presented his research on cardiac regeneration.
Drs. Matthew Sherwood and Ben Steinberg have used data from major clinical trials and registries to answer important clinical questions regarding novel oral anticoagulant therapy. They present their findings here.
We were pleased to recently host Dr. A. Jamil Tajik as the Inaugural Joseph Kisslo, MD, Visiting Professorship in Cardiovascular Imaging at Duke University. Dr. Tajik was gracious in honoring Dr. Kisslo’s leadership in cardiovascular research, mentoring and patient care. He also gave an excellent talk on the history and management of Barlow Syndrome.
Dr. Michael Reardon, Professor of Surgery at Methodist Debakey Heart and Vascular Center, and world leader in TAVR trials, speaks on the current and future directions of TAVR clinical practice and research.
Dr. Bob Bonow, Goldberg Professor of Medicine at Northwestern, Vice Chair of Medicine, and Director on the Cardiovascular Innovation Institute. He gave a great talk on the current state of the guidelines and evidenced based medicine in valvular disease.
Drs. Sean Pokorney, Meena Rao, and Christopher Granger present a case-based approach to learning the safe and effective use of novel oral anticoagulants. The session also marked the launch of noacguide.com - an extremely useful guide to help your clinical decision-making for anticoagulation in atrial fibrillation. The site is mobile friendly, includes links to risk score and dosing calculators, and features a clinical tool that can help you choose the right oral anticoagulant for your patient.
This week I attended the final meeting of the NHLBI/ United Health Centers of Excellence Steering Committee. Duke Cardiology was well represented at the meeting, which involves many global leaders in cardiovascular research. Eric Velazquez and Jerry Bloomfield attended the meeting in conjunction with collaborators from the Center of Excellence in Eldoret, Kenya. It was a unique opportunity to look to the future of cardiovascular global health research as we near the conclusion of the Center of Excellence program. This program funded 11 cardiovascular research centers across the globe including the CRONICAS research center where I work in Peru. This network has not only facilitated career development, but also has provided a mechanism for interdisciplinary collaboration. For example, my current project on household air pollution exposure and left ventricular function brings together the infrastructure of the CRONICAS Center’s population cohort study in Peru and the expertise of the Duke Cardiac Diagnostic Unit and the Duke Clinical Research Institute in conducting echocardiography-based research. These types of partnerships broaden the reach of Duke cardiovascular research worldwide.
Duke Cardiology fellow Connie Hess and her mentor Sunil Rao discuss uptake of radial access for cardiac catheterization. They review the history, latest research, and how adoption could be further improved.
Duke Cardiology fellow and DCRI Fellow Prateeti Khazanie gives a great grand rounds on device therapy in heart failure with great commentary from her mentor, Adrian Hernandez, Director of Clinical Outcomes Research at DCRI.